Search - tctmd.com

Displaying 141 - 160 of 2466

Sort: Relevancy | Date

Presentation TCT 2016

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

Presenter: Raj Makkar, Lars Sondergaard, Samir R. Kapadia

October 31, 2016

Presentation TCT 2016

Next Generation MitraClip: Whats Better and Whats Not

Presenter: Ted Feldman, Scott Lim, Ralph Stephan von Bardeleben

October 31, 2016

Presentation TCT 2016

TCT 88: Innovative Transcatheter Tricuspid Valve Repair System. Initial Outcomes From the First in Human Multi-Centre Study

Presenter: Alexander Lauten, Stephen G. Worthley, Paolo Denti

October 31, 2016

TCT 80: Transradial Diagnostic and Therapeutic Coronary Catheterization for Patients With NSTEMI or UAP Using One 4.0-Fr Sheath and One Sheathless Eaucathe Guide Catheter via One Puncture Site: 1-1-1 Trial

Presentation TCT 2016

TCT 80: Characterizing the Incidence and Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement (TAVR) and its Impact on Outcomes: A Study of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valv

Presenter: John M. Lasala, Philippe Pibarot, Saif Anwaruddin

October 31, 2016

Presentation TCT 2016

TCT 87: Transcatheter Treatment of Severe Tricuspid Regurgitation Using the MitraClip® System: 30-day Clinical Results in 13 Consecutive Patients.

Presenter: Alexander Lauten, Stephen G. Worthley, Jörg Hausleiter

October 31, 2016

Presentation TCT 2016

TCT 83: Transcatheter Aortic Valve Replacement With Different Valve Designs for Elliptic Aortic Annulus Shape

Presenter: Mayra Guerrero, Roger J. Laham, Yoshio Maeno

October 31, 2016

Presentation TCT 2016

TCT 79: Course of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With or Without Oral Anticoagulation

Presenter: John M. Lasala, Philippe Pibarot, Jürgen Rothe

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

Presentation TCT 2016

TCT 86: Early Experience With the Trialign System for Transcatheter Tricuspid Valve Repair: A Multicenter Experience

Presenter: Alexander Lauten, Stephen G. Worthley, Ermela Yzeiraj

October 31, 2016

Presentation TCT 2016

TCT 82: Evaluation of Current Practices in Transcatheter Aortic Valve Replacement: The WRITTEN (Worldwide TAVR Experience)Survey

Presenter: Mayra Guerrero, Roger J. Laham, Luis Nombela-Franco

October 31, 2016

Presentation TCT 2016

TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis

Presenter: Mayra Guerrero, Roger J. Laham, Luis Nombela-Franco

October 31, 2016

Presentation TCT 2016

TCT 77: Association of Residual Mitral Regurgitation After Transcatheter Aortic Valve Replacement With Readmission for Acute Heart Failure: An Analysis From PARTNER 1

Presenter: John M. Lasala, Philippe Pibarot, John Petersen

October 31, 2016

Presentation TCT 2016

A Single Center Study Evaluating the Long-Term Durability of Self-Expanding Transcatheter Heart Valves After Treatment of Severe Aortic Stenosis

Presenter: Spencer B. King III, Jagat Narula, Erik W. Holy

October 31, 2016

Presentation TCT 2016

TCT 44: Independent Mitral Valve Restenosis Predictors After Percutaneous Mitral Balloon Valvuloplasty in a Large, Consecutive Cohort Followed for More Than Two Decades

Presenter: Stephan Baldus, Allan Schwartz, Alfredo Nunes Ferreira Neto

October 31, 2016

Presentation TCT 2016

TCT 40: One-Year Outcome of a Multicenter Clinical Study Evaluating a Novel Self-Expanding and Resheathable Transcatheter Aortic Valve System

Presenter: Lutz Buellesfeld, Raj Makkar, Ganesh Manoharan

October 31, 2016

Presentation TCT 2016

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Philip Green

October 31, 2016

Presentation TCT 2016

A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement

Presenter: Joseph A. Hill, Steven P. Marso, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Spencer B. King III, Jagat Narula, Henrique B. Ribeiro

October 31, 2016

Presentation TCT 2016

TCT 43: Outcomes After Paravalvular Leak Closure: Percutaneous Versus Surgical Approaches

Presenter: Stephan Baldus, Allan Schwartz, John Wells

October 31, 2016

Presentation TCT 2016

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

Presenter: Lutz Buellesfeld, Raj Makkar, Ian T. Meredith

October 31, 2016

Advertisement

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

Next Generation MitraClip: Whats Better and Whats Not

TCT 88: Innovative Transcatheter Tricuspid Valve Repair System. Initial Outcomes From the First in Human Multi-Centre Study

TCT 80: Characterizing the Incidence and Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement (TAVR) and its Impact on Outcomes: A Study of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valv

TCT 87: Transcatheter Treatment of Severe Tricuspid Regurgitation Using the MitraClip® System: 30-day Clinical Results in 13 Consecutive Patients.

TCT 83: Transcatheter Aortic Valve Replacement With Different Valve Designs for Elliptic Aortic Annulus Shape

TCT 79: Course of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With or Without Oral Anticoagulation

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

TCT 86: Early Experience With the Trialign System for Transcatheter Tricuspid Valve Repair: A Multicenter Experience

TCT 82: Evaluation of Current Practices in Transcatheter Aortic Valve Replacement: The WRITTEN (Worldwide TAVR Experience)Survey

TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis

TCT 77: Association of Residual Mitral Regurgitation After Transcatheter Aortic Valve Replacement With Readmission for Acute Heart Failure: An Analysis From PARTNER 1

A Single Center Study Evaluating the Long-Term Durability of Self-Expanding Transcatheter Heart Valves After Treatment of Severe Aortic Stenosis

TCT 44: Independent Mitral Valve Restenosis Predictors After Percutaneous Mitral Balloon Valvuloplasty in a Large, Consecutive Cohort Followed for More Than Two Decades

TCT 40: One-Year Outcome of a Multicenter Clinical Study Evaluating a Novel Self-Expanding and Resheathable Transcatheter Aortic Valve System

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

TCT 43: Outcomes After Paravalvular Leak Closure: Percutaneous Versus Surgical Approaches

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content